Abstract
Intravenous cetirizine was found to be a safe, effective alternative to IV diphenhydramine, with similar efficacy in preventing reactions. It was associated with fewer adverse effects, less sedation, and reduced patient chair time, potentially improving both workflow efficiency and patient satisfaction.